Self-reported measures of antiretroviral adherence vary greatly in recall time periods and response tasks. Could 1 month recall periods be more accurate than 3 or 7 day recall periods? AIDS and Behavior
Gross hematuria and recurrent left hip septic arthritis are presented in a 55-year-old HIV-positive man diagnosed with anti-glomerular basement membrane disease. What treatments were administered? Nature Clinical Practice Nephrology
Use of once-daily tenofovir DF along with lamivudine or emtricitabine may be more effective than previous regimens for non-occupational postexposure prophylaxis (NPEP) in people at high risk for HIV infection, investigators report in the April 1st issue of the Journal of Acquired Immune Deficiency Syndromes. Reuters Health Information
Although the cardiovascular risk profile has worsened in recent years for many patients on long-term combination antiretroviral therapy for HIV infection, there has not been a corresponding increase in myocardial infarctions and other cardiovascular events, researchers report in the April 1st issue of Clinical Infectious Diseases. Reuters Health Information
HIV-infected patients who possess a common mutation in the hemochromatosis gene (HFE), and possibly those who inherit mitochondrial DNA haplogroup J, may be protected from the development of lipoatrophy associated with antiretroviral therapy (ART), research suggests. Reuters Health Information
In resource-limited settings, clinical monitoring is virtually as good as viral load or CD4+ cell count measuring to determine whether HIV-infected patients need to switch from first-line therapy to another regimen, new research suggests. Reuters Health Information
Pneumocystis colonization is common among hospitalized HIV infected patients with non-Pneumocystis pneumonia, researchers report in the April issue of Thorax. Reuters Health Information
Here Dr. Michael L. Tapper highlights the presentations from CROI 2008 regarding the epidemiology of HIV and changing patterns of HIV transmission as well as the epidemiology of hepatitis and STDs.
Here Dr. Gerald H. Friedland highlights the presentations from CROI 2008 regarding HIV and tuberculosis coinfections, including MDR and XDR TB. Medscape HIV/AIDS
